March 15 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO :
* AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* AURINIA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.04
* AURINIA PHARMACEUTICALS INC - TRIALS IN FSGS AND DRY EYE TO BEGIN IN Q2 2018